| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |